 LYON, France, December 30, 2020 -- EDAP TMS SA Nasdaq: EDAP the Company, the global leader in robotic energy- based therapies, announced today two new Focal One sales to leading U.S. healthcare institutions. The company announced a bundled sale of Focal One and Exact Vu to the University of California, San Francisco Medical Center UCSF and a Focal One sale to Cleveland Clinic. Both sales were completed during the fourth quarter. 